N. Franck and T. F. , Pharmacologie et mode d'action des neuroleptiques. EMC- Psychiatrie, pp.282-99, 2005.

M. Curran and C. Perry, Amisulpride, Drugs, vol.132, issue.2-3, pp.2123-50, 2001.
DOI : 10.2165/00003495-200161140-00014

R. Bordet, Neuroleptiques ou antipsychotiques? Typiques ou atypiques? La lettre du pharmacologue, pp.81-86, 2004.

M. Burns, The Pharmacology and Toxicology of Atypical Antipsychotic Agents, Journal of Toxicology: Clinical Toxicology, vol.151, issue.1, pp.1-14, 2001.
DOI : 10.3109/15563659709162569

N. Franck and F. , Modalités d'utilisation des neuroleptiques, EMC-Psychiatrie, vol.2005, issue.4, pp.300-339

S. Hagg, A. Jonsson, and O. Spigset, Risk of venous thromboembolism due to antipsychotic drug therapy, Expert Opinion on Drug Safety, vol.28, issue.5, pp.537-584, 2009.
DOI : 10.1177/0269881107088439

A. Walker, L. Lanza, F. Arellano, and K. Rothman, Mortality in Current and Former Users of Clozapine, Epidemiology, vol.8, issue.6, pp.671-678, 1997.
DOI : 10.1097/00001648-199710000-00010

R. Liperoti, C. Pedone, K. Lapane, V. Mor, R. Bernabei et al., Venous Thromboembolism Among Elderly Patients Treated With Atypical and Conventional Antipsychotic Agents, Archives of Internal Medicine, vol.165, issue.22, pp.2677-82, 2005.
DOI : 10.1001/archinte.165.22.2677

S. Hagg, A. Bate, M. Stahl, and O. Spigset, Associations Between Venous Thromboembolism and??Antipsychotics, Drug Safety, vol.82, issue.8, pp.685-94, 2008.
DOI : 10.2165/00002018-200831080-00005

S. Hagg, O. Spigset, and T. Soderstrom, Association of venous thromboembolism and clozapine, The Lancet, vol.355, issue.9210, pp.1155-1161, 2000.
DOI : 10.1016/S0140-6736(00)02066-3

J. Wolstein, R. Grohmann, E. Ruther, and H. Hippius, Antipsychotic drugs and venous thromboembolism, The Lancet, vol.356, issue.9225, p.252, 2000.
DOI : 10.1016/S0140-6736(05)74503-7

G. Zornberg and H. Jick, Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study, The Lancet, vol.356, issue.9237, pp.1219-1242, 2000.
DOI : 10.1016/S0140-6736(00)02784-7

K. Lacut, L. Gal, G. Couturaud, and F. , Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case???control study, Fundamental & Clinical Pharmacology, vol.3, issue.6, pp.643-50, 2007.
DOI : 10.1001/archinte.164.21.2367

URL : https://hal.archives-ouvertes.fr/hal-00688303

S. Hagg and O. Spigset, Antipsychotic-induced venous thromboembolism: a review of the evidence, CNS Drugs, vol.16, issue.11, pp.765-76, 2002.

R. Thomassen, J. Vandenbroucke, and F. Rosendaal, Antipsychotic drugs and venous thromboembolism, The Lancet, vol.356, issue.9225, p.252, 2000.
DOI : 10.1016/S0140-6736(05)74502-5

S. Hamanaka, Y. Kamijo, and T. Nagai, Massive Pulmonary Thromboembolism Demonstrated at Necropsy in Japanese Psychiatric Patients Treated With Neuroleptics Including Atypical Antipsychotics, Circulation Journal, vol.68, issue.9, pp.850-852, 2004.
DOI : 10.1253/circj.68.850

Y. Kamijo, K. Soma, T. Nagai, K. Kurihara, and T. Ohwada, Acute Massive Pulmonary Thromboembolism Associated With Risperidone and Conventional Phenothiazines, Circulation Journal, vol.67, issue.1
DOI : 10.1253/circj.67.46

E. Weinmann and E. Salzman, Deep-Vein Thrombosis, New England Journal of Medicine, vol.331, issue.24, pp.1630-1671, 1994.
DOI : 10.1056/NEJM199412153312407

V. Snow, A. Qaseem, and P. Barry, Management of Venous Thromboembolism: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians, Annals of Internal Medicine, vol.146, issue.3, pp.204-214, 2007.
DOI : 10.7326/0003-4819-146-3-200702060-00149

R. Thomassen, J. Vandenbroucke, and F. Rosendaal, Antipsychotic medication and venous thrombosis, The British Journal of Psychiatry, vol.179, issue.1, pp.63-69, 2001.
DOI : 10.1192/bjp.179.1.63

T. Ihde-scholl, M. Rolli, and J. Jefferson, Clozapine and Pulmonary Embolus, American Journal of Psychiatry, vol.158, issue.3, pp.499-500, 2001.
DOI : 10.1176/appi.ajp.158.3.499

J. Knudson, C. Kortepeter, G. Dubitsky, S. Ahmad, and M. Chen, Antipsychotic drugs and venous thromboembolism, The Lancet, vol.356, issue.9225, pp.252-255, 2000.
DOI : 10.1016/S0140-6736(05)74504-9

R. Maly, J. Masopust, L. Hosak, and K. Konupcikova, Assessment of risk of venous thromboembolism and its possible prevention in psychiatric patients, Psychiatry and Clinical Neurosciences, vol.53, issue.1, pp.3-8, 2008.
DOI : 10.1016/0049-3848(90)90422-9

S. Axelsson, S. Hagg, A. Eriksson, T. Lindahl, and P. Whiss, IN VITRO EFFECTS OF ANTIPSYCHOTICS ON HUMAN PLATELET ADHESION AND AGGREGATION AND PLASMA COAGULATION, Clinical and Experimental Pharmacology and Physiology, vol.169, issue.8, pp.775-80, 2007.
DOI : 10.1056/NEJMoa022157

S. Schneeweiss, J. Seeger, J. Landon, and A. Walker, Aprotinin during Coronary-Artery Bypass Grafting and Risk of Death, New England Journal of Medicine, vol.358, issue.8, pp.771-83, 2008.
DOI : 10.1056/NEJMoa0707571

P. Hauptman, M. Schnitzler, J. Swindle, and T. Burroughs, Use of Nesiritide Before and After Publications Suggesting Drug-Related Risks in Patients With Acute Decompensated Heart Failure, JAMA, vol.296, issue.15, pp.1877-84, 2006.
DOI : 10.1001/jama.296.15.1877

M. Main, A. Ryan, T. Davis, M. Albano, L. Kusnetzky et al., Acute Mortality in Hospitalized Patients Undergoing Echocardiography With and Without an Ultrasound Contrast Agent (Multicenter Registry Results in 4,300,966 Consecutive Patients), 31. WHO Collaborating Center for Drug Statistics and Methodology web site -URL, pp.9661742-9661748, 2008.
DOI : 10.1016/j.amjcard.2008.08.019

R. White, L. Brickner, and K. Scannell, ICD-9-CM codes poorly indentified venous thromboembolism during pregnancy, Journal of Clinical Epidemiology, vol.57, issue.9, pp.985-993, 2004.
DOI : 10.1016/j.jclinepi.2004.02.003

P. Casez, . Lj, M. Sevestre, M. Haddouche, X. Courtois et al., ICD-10 hospital discharge diagnosis codes were sensitive for identifying pulmonary embolism but not deep vein thrombosis. journal of clinical epidemiology
URL : https://hal.archives-ouvertes.fr/hal-00453690

V. Tapson, Acute Pulmonary Embolism, New England Journal of Medicine, vol.358, issue.10, pp.1037-52, 2008.
DOI : 10.1056/NEJMra072753

M. Charlson, P. Pompei, K. Ales, and C. Mackenzie, A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation, Journal of Chronic Diseases, vol.40, issue.5, pp.373-83, 1987.
DOI : 10.1016/0021-9681(87)90171-8

H. Quan, V. Sundararajan, and P. Halfon, Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data, Medical Care, vol.43, issue.11, pp.1130-1139, 2005.
DOI : 10.1097/01.mlr.0000182534.19832.83

P. Kyrle and S. Eichinger, Deep vein thrombosis, The Lancet, vol.365, issue.9465, pp.1163-74, 2005.
DOI : 10.1016/S0140-6736(05)71880-8

P. Stein, A. Beemath, and R. Olson, Trends in the Incidence of Pulmonary Embolism and Deep Venous Thrombosis in Hospitalized Patients, The American Journal of Cardiology, vol.95, issue.12, pp.1525-1531, 2005.
DOI : 10.1016/j.amjcard.2005.02.030

R. Aparasu and V. Bhatara, Antipsychotic Use and Expenditure in the United States, Psychiatric Services, vol.57, issue.12, p.1693, 2006.
DOI : 10.1176/ps.2006.57.12.1693

R. Aparasu, V. Bhatara, and S. U. Gupta, U.S. National Trends in the Use of Antipsychotics During Office Visits, 1998???2002, Annals of Clinical Psychiatry, vol.53, issue.3, pp.147-52, 1998.
DOI : 10.1080/10401230591002084

L. Citrome and J. Volavka, Optimal Dosing of Atypical Antipsychotics in Adults: A Review of the Current Evidence, Harvard Review of Psychiatry, vol.10, issue.5, pp.280-91, 2002.
DOI : 10.1080/10673220216279

J. Lieberman, T. Stroup, and J. Mcevoy, Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia, New England Journal of Medicine, vol.353, issue.12, pp.1209-1232, 2005.
DOI : 10.1056/NEJMoa051688

R. Aparasu, E. Jano, and V. Bhatara, Concomitant antipsychotic prescribing in US outpatient settings, Research in Social and Administrative Pharmacy, vol.5, issue.3, pp.234-275, 2009.
DOI : 10.1016/j.sapharm.2008.08.005

M. Briot, Rapport sur le bon usage des médicaments psychotropes: Assemblée Nationale, 2006.

. Ministère-français-de-la-santé-url, Dossier Le plan Psychiatrie et santé mentale, 2010.

L. Parkin, D. Skegg, G. Herbison, and C. Paul, Psychotropic drugs and fatal pulmonary embolism, Pharmacoepidemiology and Drug Safety, vol.30, issue.8, pp.647-52, 2003.
DOI : 10.1002/pds.841

A. Reif, M. Schneider, S. Kamolz, and B. Pfuhlmann, Homocysteinemia in psychiatric disorders: association with dementia and depression, but not schizophrenia in female patients, Journal of Neural Transmission, vol.110, issue.12, pp.1401-1412, 2003.
DOI : 10.1007/s00702-003-0061-3